Genovate, ScinoPharm co-develop Hep B Drug

Singapore: Taiwan based Genovate Biotechnology and ScinoPharm have jointly developed the highly potent oral generic drug...

November 14, 2013 | Thursday | News
Roche acquires respiratory therapy firm at $8.3 bn

Singapore: Global biopharmaceutical company, Roche, has acquired InterMune, a biotechnology company focused on the resea...

August 27, 2014 | Wednesday | News
Neurocrine Biosciences collaborates with Mitsubishi Tanabe Pharma

Nasdaq-listed Neurocrine Biosciences has entered into an exclusive collaboration and licensing agreement for the develop...

April 5, 2015 | Sunday | News
Daiichi Sankyo initiates TaNeDS drug discovery program in Europe

Tokyo: Japan's Daiichi Sankyo Company Limited has announced details of the application for its Take a New Challenge for ...

October 1, 2015 | Thursday | News
Aussie firm gets FDA green flag for oncology drug

Singapore: Australia biotech firm, Prescient Therapeutics, a clinical stage oncology company, has secured agreement from...

April 2, 2015 | Thursday | Regulatory
Pomalidomide Celgene gets EU nod for multiple myeloma

Singapore: European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing a...

June 4, 2013 | Tuesday | Regulatory
Spinifex capitalizes on pain management market

Realizing the need for improved therapies in the highly unmet field of pain management, Australia-based Spinifex has bee...

March 14, 2012 | Wednesday | News
Gilead's Viread patent revoked in China

Singapore: China's State Intellectual Property Office (SIPO) has yanked the patent for Gilead Sciences popular HIV and h...

August 8, 2013 | Thursday | News
Companion diagnostic drug for prostate cancer from Japan

Singapore: Japan's Tokai Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel therapi...

March 17, 2015 | Tuesday | News
Biogen, Elan drug effective for multiple sclerosis

Singapore: A study conducted on Biogen and Elan Pharmaceuticals's natalizumab has been shown to be effective for treatin...

March 11, 2013 | Monday | News
Roche, AstraZeneca form firm to share R&D data

Singapore: Roche and AstraZeneca entered into a collaboration to share early research data generated by Matched Molecula...

June 27, 2013 | Thursday | News
EMA says no to risky schizophrenia drug

Singapore: European Medicines Agency's (EMA) Committee for Medicinal Product for Human Use (CHMP) has issued a negative ...

December 14, 2012 | Friday | Regulatory
HUYA partners with Shanghai Zhangjiang Biotech

Singapore: HUYA Bioscience International has entered into a collaborative partnership with Shanghai Zhangjiang Biotech a...

March 7, 2013 | Thursday | News
Zydus, Pieris to develop anticalin-based protein drug

Singapore: India-based Zydus Cadila and Pieris, a next generation therapeutic protein R&D company, have entered int...

October 18, 2013 | Friday | News
Eli Lilly and Kowa Pharma report positive results of PREVAIL study

Singapore: Kowa Pharmaceuticals America and Eli Lilly and Company revealed results of the PREVAIL study that was held in...

June 1, 2012 | Friday | News
Singapore's Aslan secures $34 mn funding

Singapore: Aslan Pharmaceuticals, Singapore biotech company focused on the development of immunotherapies and targeted ...

December 9, 2015 | Wednesday | News
BI drug gets 'breakthrough therapy designation'

Singapore: Boehringer Ingelheim has recieved 'breakthrough therapy' designation from US Food & Drug Administration (...

July 23, 2014 | Wednesday | News
Strides subsidiary gets FDA nod for cancer drug

Singapore: Onco Therapies Limited, a wholly-owned subsidiary ofStrides Arcolab, received final abbreviated new drug appl...

September 4, 2012 | Tuesday | Regulatory